Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluates the immunogenicity and safety of \'IL-YANG Quadrivalent Influenza Vaccine Inj.\' in healthy male and female adults at the age of 19 or older.
Epistemonikos ID: cd5c2d479d6e4aa48a1bc4f5fa2c7b0b278fb555
First added on: May 12, 2024